Related Experiment Video

Updated: May 24, 2026

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

Optimization of important early ADME(T) parameters of NADPH oxidase-4 inhibitor molecules

Gábor Borbély1, Ménika Huszár, Attila Varga

  • 1Pathobiochemistry Research Group of Hungarian Academy of Sciences, Department of Medical Chemistry, Semmelweis University, Budapest, Hungary. gabor.borbely@kkk.org.hu

Medicinal Chemistry (Shariqah (United Arab Emirates))
|March 6, 2012
PubMed

Insights

This study optimizes NADPH oxidase 4 (NOX4) inhibitors, focusing on chromanone compounds. Researchers improved drug-like properties like lipophilicity and permeability, crucial for developing new treatments for oxidative stress diseases.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • NADPH oxidase (NOX) enzymes produce reactive oxygen species (ROS), implicating them in oxidative stress-related diseases.
  • Previous work established NOX4 inhibitory effects of diverse molecular sub-libraries and their biological significance.
  • Prior research also explored potential anti-tumour molecules, linking biological activity to physico-chemical properties.

Purpose of the Study:

  • To conduct further physico-chemical and biological investigations on NOX4 inhibitory chromanone compounds.
  • To optimize early ADME(T) parameters, including lipophilicity, phospholipophilicity, and permeability, in relation to structure-activity relationships.
  • To compare chromanone and isochromanone molecular libraries regarding lipo- and phospholipophilicity and predict substituent effects on permeability.

Main Methods:

  • Optimization of early ADME(T) parameters (lipophilicity, phospholipophilicity, permeability).
  • Structure-activity relationship (SAR) analysis of chromanone compounds.
  • Comparative analysis of chromanone and isochromanone molecular libraries.
  • Prediction of substituent effects on key physico-chemical properties and biological differences.

Main Results:

  • Demonstrated that optimal lipo- and phospholipophilicity can be determined for NOX4 inhibitors.
  • Provided a comparison between chemically similar isochromanone and chromanone molecular libraries.
  • Showcased methods to predict the impact of substituents on permeability, lipo-, and phospholipophilicity.

Conclusions:

  • Established methods for optimizing ADME(T) properties of NOX4 inhibitors, specifically chromanone derivatives.
  • Highlighted the importance of lipophilicity and permeability in drug design for NOX4-targeted therapies.
  • Delineated biological differences between anti-tumour molecules and NOX4 inhibitors based on penetration ability.

More Related Videos

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases08:57

Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases

Published on: February 24, 2018

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...